SVSophia Vincoff

Sophia Vincoff

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sophia Vincoff has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SNOOPPI: a sequence-normalized database of on- and off-target protein–protein interactions

    by Sophia Vincoff, Pranam Chatterjee

    Motivation: Protein–protein interactions (PPIs) are central to biological processes and therapeutic interventions. While many databases document known PPIs, these resources often lack evidence-based negatives and clear identification of the specific proteoforms tested. Results: Here, we introduce SNOOPPI, a Sequence-Normalized database of on- and off-target protein–protein interactions, which represents the first unified dataset of binary PPIs that is isoform, post-translational modification, mutation, and binding site aware. By defining a PPI as a direct, physical interaction between two amino acid sequences, SNOOPPI overcomes several persistent limitations of existing PPI databases. SNOOPPI was curated from the IntAct database, taking full advantage of its experimental metadata and feature annotations to reclassify and uncover new PPIs. The final dataset comprises over 33.6K positive interactions and 5.3K negative interactions. SNOOPPI also retains over 835K unresolved interactions, explicitly capturing gaps in the experimental literature. Beyond its usefulness as a reference dataset for the scientific community, SNOOPPI has the potential to serve as a high-confidence foundation for sequence-based modeling, benchmarking, and generative design of novel protein and peptide interactors. Availability and implementation: The full database can be accessed and downloaded through an interactive Hugging Face page: https://huggingface.co/datasets/ChatterjeeLab/SNOOPPI. All code is open-source and maintained at https://github.com/sophievincoff/snooppi. The database and associated code will be updated periodically to incorporate new IntAct releases. The specific version of the code associated with this publication is archived at the following Zenodo repository: https://doi.org/10.5281/zenodo.22116350.

  • Open Access

    Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations in vitro and in vivo

    by Tianzheng Ye, Azmain Alamgir, Cara M. Robertus, Darianna Colina, Connor Monticello, Thomas Connor Donahue, Chandra Bandi, Lauren Hong, Sophia Vincoff, Shrey Goel, et al.

    Aberrant activation of Wnt signaling results in unregulated accumulation of cytosolic β-catenin, which subsequently enters the nucleus and promotes transcription of genes that contribute to cellular proliferation and malignancy. Here, we sought to eliminate pathogenic β-catenin from the cytosol using designer ubiquibodies (uAbs), chimeric proteins composed of an E3 ubiquitin ligase and a target-binding domain that redirect intracellular proteins to the proteasome for degradation. To accelerate uAb development, we leveraged a protein language model–driven algorithm called SaLT&PepPr to computationally design “guide” peptides with affinity for β-catenin, which were subsequently fused to the catalytic domain of a human E3 called carboxyl terminus of Hsp70-interacting protein. Expression of the resulting peptide-guided uAbs in colorectal cancer cells led to the identification of several designs that greatly reduced the abnormally stable pool of free β-catenin in the cytosol and nucleus while preserving the normal membrane–associated subpopulation. This selective knockdown of pathogenic β-catenin suppressed Wnt/β-catenin signaling and impaired tumor cell survival and proliferation. Furthermore, one of the best degraders selectively decreased cytosolic but not membrane-associated β-catenin levels in livers of BALB/c mice following delivery as a lipid nanoparticle–encapsulated mRNA. Collectively, these findings reveal the unique ability of uAbs to selectively deplete abnormal proteins in vitro and in vivo and open the door to peptide-programmable biologic modulators of other disease-causing proteins.


  • Top Cited Papers
    Open Access

    De novo design of peptide binders to conformationally diverse targets with contrastive language modeling

    by Suhaas Bhat, Kalyan Palepu, Lauren Hong, Joey Mao, Tianzheng Ye, Rema Iyer, Lin Zhao, Tianlai Chen, Sophia Vincoff, Rio Watson, et al.

    Designing binders to target undruggable proteins presents a formidable challenge in drug discovery. In this work, we provide an algorithmic framework to design short, target-binding linear peptides, requiring only the amino acid sequence of the target protein. To do this, we propose a process to generate naturalistic peptide candidates through Gaussian perturbation of the peptidic latent space of the ESM-2 protein language model and subsequently screen these novel sequences for target-selective interaction activity via a contrastive language-image pretraining (CLIP)–based contrastive learning architecture. By integrating these generative and discriminative steps, we create a Peptide Prioritization via CLIP (PepPrCLIP) pipeline and validate highly ranked, target-specific peptides experimentally, both as inhibitory peptides and as fusions to E3 ubiquitin ligase domains. PepPrCLIP-derived constructs demonstrate functionally potent binding and degradation of conformationally diverse, disease-driving targets in vitro. In total, PepPrCLIP empowers the modulation of previously inaccessible proteins without reliance on stable and ordered tertiary structures.